¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 : 2021-02-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 : 2021-02-20
±³À°ÀÏÀÚ : 2021-02-20
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021      
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ½ÅÀåÇÐȸ»ç¹«±¹
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : ksn@ksn.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í 1Àϵî·Ï½Ã 50,000¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 20ÀÏ  09:10~09:40 Key issues in the management of electrolyte and acid-base disorders  ±è±ÙÈ£(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  09:40~10:10 Calcium metabolism in general population and kidney disease patients: an overview  ¹èÀºÈñ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  10:10~10:40 Proper use of diuretics: oldies but goodies  À¯°æµ·(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  10:50~11:20 The role of continuous renal replacement therapy in sepsis-induced AKI  Á¶ÀåÈñ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  11:20~11:50 AKI in patients with hepatic failure: hepatorenal syndrome vs. septic AKI  ÃÖÈÆ¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  11:50~12:20 Fluid and nutritional management of AKI patients: during vs. after CRRT  ÀåÇý·Ã(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  13:20~13:50 Glomerular disease: evaluation and differential diagnosis  ¹®ÁÖ¿µ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  13:50~14:20 Evidence-based clinical practice guidelines for nephrotic syndrome  ¼Û»óÇå(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  14:20~14:50 Overview of the classification and treatment of crescentic glomerulonephritis  ÁøÈ£ÁØ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  14:50~15:20 Differential diagnosis and treatment of thrombotic microangiopathies  ÃÖ´ëÀº(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  15:30~16:00 Transplant immunobiology  ÀÌÁ¾¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  16:00~16:30 Immunologic test & monitoring in kidney transplant recipients  ±è¹ü¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  16:30~17:00 Recent advances in evaluation & management for transplant rejection  Çѽ¿±(°è¸íÀÇ´ë) 
±³À°½Ã°£ 02¿ù 20ÀÏ  17:00~17:30 ABO-incompatible KT & HLA-incompatible KT: update  ¾çö¿ì(°¡Å縯ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) Á¦14ȸ Nephrology Board Review Course 2021 : 2021-02-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦22ȸ ü°èÀû ¹®Çå °íÂû(¸ÞŸºÐ¼®)À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©샾 : 2021-02-20
´ÙÀ½±Û °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦22ȸ ü°èÀû ¹®Çå °íÂû(¸ÞŸºÐ¼®)À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©샾 : 2021-02-19
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
527 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø ECHO SEOUL 2018 : 2018-09-14 0 543 2018-08-22
526 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-14 0 887 2018-08-22
525 ¼­¿ï ´ëÇѼҾƽŰæÇÐȸ µÎÅ뿬±¸È¸ ÇмúÁý´ãȸ : 2018-09-14 0 835 2018-08-22
524 ÀüºÏ ´ëÇÑÀÇ»çÇùȸ 2018 Àü¶óºÏµµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° (2Â÷) : 2018-09-14 0 1,719 2018-08-22
523 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-14 0 782 2018-08-22
522 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø Practical Disaster Preparedness - from Evidence to Practice : 2018-09-13 0 889 2018-08-22
521 ÀüºÏ 2018 Àü¶óºÏµµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° (1Â÷) : 2018-09-13 0 1,118 2018-08-22
520 °æ±â °í·Á´ëÇб³ ¾È»êº´¿ø ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¦77Â÷ ¿ù·ÊÁý´ãȸ : 2018-09-13 0 1,013 2018-08-22
519 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø À̺ñÀÎÈÄ°ú 2Çбâ Áö¿ªÀÇ»çÁý´ãȸ : 2018-09-13 0 499 2018-08-22
518 ºÎ»ê ´ëÇÑ°ñ´ë»çÇÐȸ 2018³â ºÎ»ê,¿ï»ê,°æ³²Áöȸ Á¦2Â÷ Áý´ãȸ : 2018-09-12 0 720 2018-08-22
517 ±¤ÁÖ Á¶¼±´ëº´¿ø Á¦ 157Â÷ ´ëÇÑÇǺΰúÇÐȸ È£³²Áöȸ : 2018-09-12 0 818 2018-08-22
516 ÀÎõ ÀÎõ¼º¸ðº´¿ø ´ëÇÑÇǺΰúÇÐȸ Á¦39Â÷ ÀÎõÁöºÎȸ ÇмúÁý´ãȸ : 2018-09-12 0 2,782 2018-08-22
515 ÀÎõ ±æº´¿ø Çѱ¹¿©ÀÚÀÇ»çȸ ºñŸ¹ÎDÀÇ ÀÌÇØ¿Í ÀÓ»óÀû¿ë : 2018-09-12 0 1,441 2018-08-22
514 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø À̺ñÀÎÈÄ°ú Çù·Âº´ÀÇ¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-11 0 1,099 2018-08-22
513 °æ±â °í·Á´ë¾È»êº´¿ø ´ëÇÑÇǺΰúÇÐȸ Á¦ 60Â÷ °æ±âÁöºÎȸ ÇмúÁý´ãȸ : 2018-09-11 0 1,791 2018-08-22
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷